The Big Apple

Bankers throw lifeline to stricken Southern Cross

UK's largest care homes operator is allowed to extend loan facilities until October to enable property assets sale

GSK to break up R&D operations

Alliance formed with Aspen of South Africa as under-pressure pharmaceuticals group announces plans for smaller R&D units

Roche bid for Genentech faces lawsuit

Roche’s $43.7bn (£21.8 bn) takeover of Genentech was met with a lawsuit claiming that the deal short-changed shareholders

GSK in tie-up with low-cost drugs group

Pharmaceuticals giant announces alliance with South African company to increase access to low cost generic drugs

Roche pursues Genentech to fight off rivals

Swiss drugs company Roche made a $43.7bn cash bid for the remaining stake in Genentech, its San Francisco-based partner

Roche bids $44bn for Genentech stake

Swiss drugs giant launches offer for its US partner to gain control of its cancer drugs and new medicines

Ranbaxy faces US fraud probe over drug claims

The investigation, by the US Food and Drug Administration, could affect Daiichi's $4.6bn takeover of Ranbaxy

Shares in Oxford Biomedica plummet

The biotechnology company discloses that its important kidney cancer vaccination drug TroVax has failed in key tests

'Why was I going after the 10% who exercise?'

Martin Waller talks to a man who started selling a gym product then found a bigger market among the office couch potatoes

Oxford BioMedica plunges on drug trial blow

Deaths of kidney cancer patients force end of drug trial by UK biotech group that was working with Sanofi-Aventis

Takeover talk boosts shares in Concateno

Company that conducts eight million drugs tests a year in prisons and for courts says it has received several approaches

Fresenius buys APP in $3.7bn deal

Buying IV generic drugs company will give dialysis specialist Fresenius foothold in American market

Chai Patel on healthcare sector buying spree

The entrepreneur will use family money to launch a comeback and has set up an acquisition vehicle called Court Cavendish

RBS seeks care merger for Priory

The bank is holding discussions about a merger that would lead to a radical shake-up of Britain’s healthcare sector

Occupancy fears hit shares in Southern Cross

The UK care homes operator may have far more empty beds than shareholders previously believed, as shares fall 14.5 per cent